Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil

Journal of Rheumatology

Volumn 33, Issue 2, 2006, Pages 307-310

  Madland, Tor Magne ^a,b   Björkkjær, Tormod ^a   Brunborg, Linn Anne ^c   Fröyland, Livar ^c   Berstad, Arnold ^a   Brun, Johan G ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NIFES ^*  (Norway)

Author keywords

Calprotectin; Eicosanoids; Polyunsaturated fatty acids; Psoriatic arthritis; Seal oil; Soy oil

Indexed keywords

ARACHIDONIC ACID; CALPROTECTIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; FISH OIL; HYDROXYCHLOROQUINE; ICOSAPENTAENOIC ACID; LEFLUNOMIDE; LINOLEIC ACID; LINOLENIC ACID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; SEAL OIL; SOYBEAN OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG ACTIVITY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FECES ANALYSIS; FEMALE; HUMAN; LIPID COMPOSITION; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HEALTH STATUS; PILOT PROJECTS; SEALS, EARLESS; SEVERITY OF ILLNESS INDEX; SOYBEAN OIL; TREATMENT OUTCOME;

EID: 32144463306     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. De Keyser F, Mielants H. The gut in ankylosing spondylitis and other spondylo-arthropathies: Inflammation beneath the surface. J Rheumatol 2003;30:2306-7.
2. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004;50:3762-71.
3. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50-4.
4. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003;63:845-53.
5. Arslan G, Brunborg LA, Fröyland L, Brun JG, Valen M, Berstad A. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids 2002;37:935-40.
6. Bjorkkjaer T, Brunborg LA, Arslan G, et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand J Gastroenterol 2004;39:1088-94.
7. Stulnig TM. Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol 2003;132:310-21.
8. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56:365-79.
9. Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003;38:343-52.
10. Bros J, Olaussen K, Österud B, et al. A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects. Lipids 2001;36:7-13.
11. Yoshida H, Kumamaru J, Mawatari M, et al. Lymphatic absorption of seal and fish oils and their effect on lipid metabolism and eicosanoid production in rats. Biosci Biotechnol Biochem 1996;60:1293-8.
12. Small DM. The effects of glyceride structure on absorption and metabolism. Annu Rev Nutr 1991;11:413-34.
13. Van Riel P. EULAR handbook of clinical assessment in rheumatoid arthritis. Nijmegen:EULAR; 2000.
14. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
15. Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994;21:733-8.
16. Kane D, Roth J, Frosch M, Vogl T, Bresnihan B, FitzGerald O. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum 2003;48:1676-85.
17. Scarpa R, Manguso F, D'Arienzo A. et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 2000;27:1241-6.